業績・論文 2017

*脳脊髄腫瘍科

1.Aihara K, Mukasa A, Nagae G, Nomura M, Yamamoto S, Ueda H, Tatsuno K, Shibahara J, Takahashi M, Momose T, Tanaka S, Takayanagi S, Yanagisawa S, Nejo T, Takahashi S, Omata M, Otani R, Saito K, Narita Y, Nagane M, Nishikawa R, Ueki K, Aburatani H, Ssaito H.  Genetic and epigenetic stability of oligodendrogliomas at recurrence.  Acta Neuropathol Commun 5:18, 2017

2.Miyake Y, Mishima K, Suzuki T, Adachi JI, Sasaki A, Nishikawa R.  Hemorrhagic ganglioglioma of the third ventricle with atypical pathological findings.  Brain Tumor Pathol 34:135-137, 2017

3.Wakabayashi T, Iuchi T, Tsuyuguchi N, Nishikawa R, Arakawa Y, Sasayama T, Miyake K, Nariai T, Narita Y, Hashimoto N, Okuda O, Matsuda H, Kubota K, Ito K, Nakazato Y, Kubomura K.  Diagnostic performance and safety of positron emission tomography using 18F-fluciclovine in patients with clinically suspected high- or low-grade gliomas.  Amulticenter phase IIb trial.  Asia Ocean J Nucl Med Biol 5:10-21, 2017.

4.Wang W, Zhang H, Liu S, Kim CK, Xu Y, Hurley LA, Nishikawa R, Nagane M, Hu B, Stegh AH, Cheng SY, Cheng C.  Internalized CD44s splice isoform attenuates EGFR degradation by targeting Rab7A.  Proc Natl Acad Sci USA 114:8366-8371, 2017

5.George J, Saito M, Tsuta K, Iwakara R, Shiraishi K, Scheel A, Uchida S, Watanabe SI, Nishikawa R, Noguchi M, Peifer M, Petersen I, Jang SJ, Buttners R, Harris CC, Yokota J, Thomas RK, Kohno T.  Genomic Amplification of CD274 (PD-L1) in Small-Cell Lung Cancer.  Clin Cancer Res 23:1220-1226, 2017

6.Fukushima S, Yamashita S, Kobayashi H, Takami H, Fukuoka K, Nakamura T, Yamasaki K, Matsushita Y, Nakamura H, Totoki Y, Kato M, Suzuki T, Kazuhiko M, Takaaki Y, Akitake M, Saito N, Kanamori M, Kumabe T, Tominaga T, Nagane M, Iuchi T, Nakada M, Yokogami K, Takeshima H, Kanemura Y, Matsuda M, Matsumura A, Kurozumi K, Ueki K, Nonaka M, Asai A, Kawahara N, Hirose Y, Takayama T, Nakazato Y, Narita Y, Shibata T, Matsutani M, Ushijima T, Nishikawa R, Ichimura K.  Genome-wide methylation profiles in primary intracranial germ cell tumors indicate a primordial germ cell origin for germinoma.  Acta Neuropathol 133:445-462, 2017

7.Perry JR, Laperriere N, O’Callaghan CJ, Brandes AA, Menten J, Phillips C, Fay M, Nishikawa R, Cairncross JG, Roa W, Osoba D, Rossiter JP, Sahgal A, Hirte H, Laigle-Donadey F, Franceschi E, Chinot O, Golfinopoulos V, Fariselli L, Wick A, Feuvret L, Backk M, Tillis M, Winch C, Baumert BG, Wick W, Ding K, Mason WP, Trial Investigators.  Short-course radiation plus temozolomide in elderly patients with glioblastoma.  N Engl J Med 376:1027-1037, 2017.

8.Nomura M, Mukasa A, Nagae G, Yamamoto S, Tatsuno K, Ueda H, Fukuda S, Umeda T, Suzuki T, Otani R, Kobayashi K, Maruyama T, Tanaka S, Takayanagi S, Nejo T, Takahashi S, Ichimura K, Nakamura T, Muragaki Y, Narita Y, Nagane M, Ueki K, Nishikawa R, Shibahara J, Aburatani H, Saito N.  Distinct molecular profile of diffuse cerebellar gliomas.  Acta Neuropathol epub 2017 Aug 29

9.Miyake Y, Adachi JI, Suzuki T, Mishima K, Sasaki A, Nishikawa R.  Craniospinal germinomas in patients with down syndrome successfully treated with standard-dose chemotherapy and craniospinal irradiation:  case report and literature review.  World Neurosurg 2017 Sep 12

10.Nakamura Y, Teramoto Y, Asami Y, Matsuya T, Adachi JI, Nishikawa R, Yamamoto A.  Nivolumab Therapy for Treatment-Related Vitiligo in a PatientWith Relapsed Metastatic Melanoma.  JAMA Dermatology 153:942-944, 2017

11.Mehta M, Wen P, Nishikawa R, Reardon D, Peters K.  Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients.  Crit Rev Oncol Hematol 2017 Mar, 111:60-65

12.Huang T, Kim CK, Alvarez AA, Pangeni RP, Wan X, Song X, Shi T, Yang Y, Norbinski CM, Lu S, Stupp R, Kessler JA, Nishikawa R, Nakano I, Sulman EP, Lu X, James CD, Yin XM, Hu B, Cheng SY.  MST4 phosphorylation of ATG4B regulates autophagic activity, tumorigenicity, and radioresistance in glioblastoma.  Cancer Cell 32:840-855, 2017

13.Takayanagi S, Mukasa A, Nakatomi H, Kanno H, Kuratsu JI, Nishikawa R, Mishima K, Natsume A, Wakabayashi T, Houkin K, Terasaka S, Yao M, Shinohara N, Shuin T, Saito N. Development of Database and Genomic Medicine for von Hippel-Lindau Disease in Japan. Neurol Med Chir (Tokyo). 2017 Feb 15;57(2):59-65.

14.Nakamura T, Yamashita S, Fukumura K, Nakabayashi J, Tanaka K, Tamura K, Tateishi K, Kinoshita M, Fukushima S, Takami H, Fukuoka K, Yamazaki K, Matsushita Y, Ohno M, Miyakita Y, Shibui S, Kubo A, Shuto T, Kocialkowski S, Yamanaka S, Mukasa A, Sasayama T, Mishima K, Maehara T, Kawahara N, Nagane M, Narita Y, Mano H, Ushijima T, Ichimura K. Genome-wide DNA methylation profiling identifies primary central nervous system lymphoma as a distinct entity different from systemic diffuse large B-cell lymphoma.
Acta Neuropathol. 2017 Feb;133(2):321-324.

15.Miyake Y, Mishima K, Suzuki T, Adachi JI, Sasaki A, Nishikawa R.

Hemorrhagic ganglioglioma of the third ventricle with atypical pathological findings.
Brain Tumor Pathol. 34(3):135-137. 2017

16.三島一彦 鈴木 論:Gangliocytoma, Ganglioglioma, Anaplastic ganglioglioma. 脳腫瘍臨床病理カラーアトラス 第4版pp. 75-76 医学書院 2017
ページの先頭へ トップページへ